Results for tag: "Encephalomyelitis Drug"

Encephalomyelitis is a type of inflammatory disease of the central nervous system (CNS) that affects the brain and spinal cord. It is caused by a variety of infectious agents, including viruses, bacteria, fungi, and parasites. The symptoms of encephalomyelitis can range from mild to severe, and can include fever, headache, confusion, seizures, and paralysis. Treatment of encephalomyelitis typically involves a combination of medications, including antiviral drugs, antibiotics, antifungal drugs, and immunosuppressants. The encephalomyelitis drug market is a subset of the larger CNS drug market, which includes drugs used to treat a variety of neurological disorders, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. The encephalomyelitis drug market is highly competitive, with a number of companies offering a variety of treatments. Some of the major companies in the encephalomyelitis drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. These companies offer a range of treatments, including antiviral drugs, antibiotics, antifungal drugs, and immunosuppressants. Show Less Read more